Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Other Non-Current Assets (2016 - 2025)

Healthcare Services (HCSG) has disclosed Other Non-Current Assets for 14 consecutive years, with $3.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets fell 4.57% to $3.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.9 million, a 4.57% decrease, with the full-year FY2025 number at $3.9 million, down 4.57% from a year prior.
  • Other Non-Current Assets was $3.9 million for Q4 2025 at Healthcare Services, up from $32000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $24.7 million in Q1 2024 to a low of $32000.0 in Q3 2025.
  • A 4-year average of $4.7 million and a median of $3.8 million in 2025 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: surged 3149.34% in 2024, then tumbled 99.43% in 2025.
  • Healthcare Services' Other Non-Current Assets stood at $812000.0 in 2022, then surged by 123.4% to $1.8 million in 2023, then skyrocketed by 125.36% to $4.1 million in 2024, then dropped by 4.57% to $3.9 million in 2025.
  • Per Business Quant, the three most recent readings for HCSG's Other Non-Current Assets are $3.9 million (Q4 2025), $32000.0 (Q3 2025), and $3.6 million (Q2 2025).